Mark Lappe Transaction History

Date Transaction Value Shares Traded Form
Sep 16 2024
BUY
Open market or private purchase
$223,323 $17.13 p/Share
13,037
Sep 12 2024
BUY
Open market or private purchase
$405,793 $15.05 p/Share
26,963
Sep 10 2024
BUY
Open market or private purchase
$129,115 $15.19 p/Share
8,500
Sep 09 2024
BUY
Open market or private purchase
$144,495 $15.21 p/Share
9,500
Sep 06 2024
BUY
Open market or private purchase
$397,540 $15.29 p/Share
26,000
Sep 03 2024
BUY
Open market or private purchase
$319,800 $15.99 p/Share
20,000
Aug 30 2024
BUY
Open market or private purchase
$140,200 $14.02 p/Share
10,000
Aug 29 2024
BUY
Open market or private purchase
$140,300 $14.03 p/Share
10,000
Aug 21 2024
BUY
Open market or private purchase
$167,378 $12.93 p/Share
12,945
Aug 20 2024
BUY
Open market or private purchase
$350,903 $12.97 p/Share
27,055
May 29 2024
BUY
Grant, award, or other acquisition
-
761,413

Also insider at

INBX
Inhibrx, Inc. Healthcare
ML

Mark Lappe

Chief Executive Officer
La Jolla, CA

Track Institutional and Insider Activities on INXB

Follow Inhibrx Biosciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells INXB shares.

Notify only if

Insider Trading

Get notified when an Inhibrx Biosciences, Inc. insider buys or sells INXB shares.

Notify only if

News

Receive news related to Inhibrx Biosciences, Inc.

Track Activities on INXB